title: Detection of Ligand-Induced Conformational Changes in Oligonucleotides by Second-Harmonic Generation at a Supported Lipid Bilayer Interface.
abstract: There is a high demand for characterizing oligonucleotide structural changes associated with binding interactions as well as identifying novel binders that modulate their structure and function. In this study, second-harmonic generation (SHG) was used to study RNA and DNA oligonucleotide conformational changes associated with ligand binding. For this purpose, we developed an avidin-based biotin capture surface based on a supported lipid bilayer membrane. The technique was applied to two well-characterized aptamers, both of which undergo conformational changes upon binding either a protein or a small molecule ligand. In both cases, SHG was able to resolve conformational changes in these oligonucleotides sensitively and specifically, in solution and in real time, using nanogram amounts of material. In addition, we developed a competition assay for the oligonucleotides between the specific ligands and known, nonspecific binders, and we demonstrated that intercalators and minor groove binders affect the conformation of the DNA and RNA oligonucleotides in different ways upon binding and subsequently block specific ligand binding in all cases. Our work demonstrates the broad potential of SHG for studying oligonucleotides and their conformational changes upon interaction with ligands. As SHG offers a powerful, high-throughput screening approach, our results here also open an important new avenue for identifying novel chemical probes or sequence-targeted drugs that disrupt or modulate DNA or RNA structure and function.
authors.affiliation: Biodesy, Inc. , 384 Oyster Point Boulevard, Suite No. 8, South San Francisco, California 94080, United States.
authors.forename: Margaret T
authors.initials: MT
authors.lastname: Butko
authors.affiliation: Biodesy, Inc. , 384 Oyster Point Boulevard, Suite No. 8, South San Francisco, California 94080, United States.
authors.forename: Ben
authors.initials: B
authors.lastname: Moree
authors.affiliation: Biodesy, Inc. , 384 Oyster Point Boulevard, Suite No. 8, South San Francisco, California 94080, United States.
authors.forename: Richard B
authors.initials: RB
authors.lastname: Mortensen
authors.affiliation: Biodesy, Inc. , 384 Oyster Point Boulevard, Suite No. 8, South San Francisco, California 94080, United States.
authors.forename: Joshua
authors.initials: J
authors.lastname: Salafsky
mesh_terms: D004247:DNA / Q000737:chemistry*; D004353:Drug Evaluation, Preclinical / Q000295:instrumentation; D004867:Equipment Design; D057166:High-Throughput Screening Assays / Q000295:instrumentation; D007364:Intercalating Agents / Q000494:pharmacology*; D008024:Ligands; D008051:Lipid Bilayers / Q000737:chemistry*; D009690:Nucleic Acid Conformation; D009841:Oligonucleotides / Q000737:chemistry*; D012313:RNA / Q000737:chemistry*
chemical_list: D007364:Intercalating Agents; D008024:Ligands; D008051:Lipid Bilayers; D009841:Oligonucleotides; D012313:RNA; D004247:DNA